TY - JOUR
T1 - The effectiveness of real-time computer-aided and quality control systems in colorectal adenoma and polyp detection during colonoscopies
T2 - a meta-analysis
AU - Aslam, Muhammad Fawad
AU - Bano, Shehar
AU - Khalid, Mariam
AU - Sarfraz, Zouina
AU - Sarfraz, Azza
AU - Sarfraz, Muzna
AU - Robles-Velasco, Karla
AU - Felix, Miguel
AU - Deane, Kitson
AU - Cherrez-Ojeda, Ivan
N1 - Publisher Copyright:
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2023/2/1
Y1 - 2023/2/1
N2 - Aims: This meta-analysis aims to quantify the effectiveness of artificial intelligence (AI)-supported colonoscopy compared to standard colonoscopy in adenoma detection rate (ADR) differences with the use of computer-aided detection and quality control systems. Moreover, the polyp detection rate (PDR) intergroup differences and withdrawal times will be analyzed. Methods: This study was conducted adhering to PRISMA guidelines. Studies were searched across PubMed, CINAHL, EMBASE, Scopus, Cochrane, and Web of Science. Keywords including the following ‘Artificial Intelligence, Polyp, Adenoma, Detection, Rate, Colonoscopy, Colorectal, Colon, Rectal’ were used. Odds ratio (OR) applying 95% CI for PDR and ADR were computed. SMD with 95% CI for withdrawal times were computed using RevMan 5.4.1 (Cochrane). The risk of bias was assessed using the RoB 2 tool. Results: Of 2562 studies identified, 11 trials were included comprising 6856 participants. Of these, 57.4% participants were in the AI group and 42.6% individuals were in in the standard group. ADR was higher in the AI group compared to the standard of care group (OR = 1.51, P = 0.003). PDR favored the intervened group compared to the standard group (OR = 1.89, P < 0.0001). A medium measure of effect was found for withdrawal times (SMD = 0.25, P < 0.0001), therefore with limited practical applications. Conclusion: AI-supported colonoscopies improve PDR and ADR; however, no noticeable worsening of withdrawal times is noted. Colorectal cancers are highly preventable if diagnosed early-on. With AI-assisted tools in clinical practice, there is a strong potential to reduce the incidence rates of cancers in the near future.
AB - Aims: This meta-analysis aims to quantify the effectiveness of artificial intelligence (AI)-supported colonoscopy compared to standard colonoscopy in adenoma detection rate (ADR) differences with the use of computer-aided detection and quality control systems. Moreover, the polyp detection rate (PDR) intergroup differences and withdrawal times will be analyzed. Methods: This study was conducted adhering to PRISMA guidelines. Studies were searched across PubMed, CINAHL, EMBASE, Scopus, Cochrane, and Web of Science. Keywords including the following ‘Artificial Intelligence, Polyp, Adenoma, Detection, Rate, Colonoscopy, Colorectal, Colon, Rectal’ were used. Odds ratio (OR) applying 95% CI for PDR and ADR were computed. SMD with 95% CI for withdrawal times were computed using RevMan 5.4.1 (Cochrane). The risk of bias was assessed using the RoB 2 tool. Results: Of 2562 studies identified, 11 trials were included comprising 6856 participants. Of these, 57.4% participants were in the AI group and 42.6% individuals were in in the standard group. ADR was higher in the AI group compared to the standard of care group (OR = 1.51, P = 0.003). PDR favored the intervened group compared to the standard group (OR = 1.89, P < 0.0001). A medium measure of effect was found for withdrawal times (SMD = 0.25, P < 0.0001), therefore with limited practical applications. Conclusion: AI-supported colonoscopies improve PDR and ADR; however, no noticeable worsening of withdrawal times is noted. Colorectal cancers are highly preventable if diagnosed early-on. With AI-assisted tools in clinical practice, there is a strong potential to reduce the incidence rates of cancers in the near future.
KW - adenoma
KW - colorectal
KW - meta-analysis
KW - polyps
KW - trials
KW - withdrawal time
UR - https://www.scopus.com/pages/publications/85161546352
U2 - 10.1097/MS9.0000000000000079
DO - 10.1097/MS9.0000000000000079
M3 - Artículo de revisión
AN - SCOPUS:85161546352
SN - 2049-0801
VL - 85
SP - 80
EP - 91
JO - Annals of Medicine and Surgery
JF - Annals of Medicine and Surgery
IS - 2
ER -